Report - Farmaci Antidiabetici e Rischio Cardio-Nefro- Vascolare...Renal Outcomes with Empagliflozin 7 EMPA-REG RENAL (N=7020) *Doubling of SCr + eGFR ≤45 mL/min/1.73 m 2, initiation of renal

Please pass captcha verification before submit form